Stockscreener 앱 받기
3.60
0.55%
-0.02
시장 영업 전:
3.62
0.02
+0.56%
전일 마감가:
$3.62
열려 있는:
$3.72
하루 거래량:
3.48M
Relative Volume:
1.05
시가총액:
$833.24M
수익:
-
순이익/손실:
$-179.82M
주가수익비율:
-2.7068
EPS:
-1.33
순현금흐름:
$-159.16M
1주 성능:
+8.11%
1개월 성능:
+33.33%
6개월 성능:
+183.46%
1년 성능:
+295.60%
1일 변동 폭
$3.56
$3.79
1주일 범위
$3.34
$3.80
52주 변동 폭
$0.76
$3.80
Gossamer Bio Inc Stock (GOSS) Company Profile
명칭
Gossamer Bio Inc
전화
(858) 684-1300
주소
3115 MERRYFIELD ROW, SAN DIEGO, CA
GOSS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GOSS
Gossamer Bio Inc
|
3.60 | 837.87M | 0 | -179.82M | -159.16M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Gossamer Bio Inc Stock (GOSS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-10 | 업그레이드 | UBS | Neutral → Buy |
| 2025-07-14 | 개시 | Scotiabank | Sector Outperform |
| 2024-06-25 | 개시 | Oppenheimer | Outperform |
| 2024-04-05 | 재개 | Wedbush | Outperform |
| 2023-07-27 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-03-07 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-03-01 | 개시 | Guggenheim | Neutral |
| 2022-12-07 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2022-12-07 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2022-12-07 | 다운그레이드 | SMBC Nikko | Outperform → Neutral |
| 2022-10-20 | 개시 | Goldman | Buy |
| 2022-09-21 | 개시 | JP Morgan | Neutral |
| 2022-09-19 | 개시 | Wedbush | Outperform |
| 2022-04-18 | 개시 | Raymond James | Outperform |
| 2022-04-06 | 개시 | UBS | Buy |
| 2022-01-10 | 업그레이드 | SMBC Nikko | Neutral → Outperform |
| 2021-11-09 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-09-21 | 재개 | Piper Sandler | Overweight |
| 2020-06-29 | 개시 | H.C. Wainwright | Buy |
| 2020-04-22 | 개시 | Piper Sandler | Overweight |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2019-12-03 | 재개 | BofA/Merrill | Buy |
| 2019-10-30 | 개시 | Berenberg | Buy |
| 2019-03-05 | 개시 | Barclays | Overweight |
| 2019-03-05 | 개시 | BofA/Merrill | Buy |
| 2019-03-05 | 개시 | Evercore ISI | Outperform |
| 2019-03-05 | 개시 | SVB Leerink | Outperform |
모두보기
Gossamer Bio Inc 주식(GOSS)의 최신 뉴스
20 Stocks That Will Double in 2026 - Insider Monkey
Gossamer Bio (NASDAQ:GOSS) Hits New 1-Year HighTime to Buy? - MarketBeat
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)December 9, 2025 - BioSpace
Gossamer Bio announces inducement grant under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Gossamer Bio Inc (GOSS) is looking forward to a strong quarter - setenews.com
Gossamer Bio (NASDAQ:GOSS) Stock Price Up 5.9%Still a Buy? - MarketBeat
Is Gossamer Bio Stock Built to Withstand a Pullback? - Trefis
What RSI levels show for Gossamer Bio Inc. (4GB) stockJuly 2025 Retail & Risk Adjusted Swing Trade Ideas - Newser
Adversity is less terrifying than hope: Gossamer Bio Inc (GOSS) - setenews.com
Why millennials buy Gossamer Bio Inc. (4GB) stockJuly 2025 Analyst Calls & Precise Buy Zone Tips - Newser
Will Gossamer Bio Inc. stock maintain growth storyJuly 2025 Patterns & Community Supported Trade Ideas - Newser
How Recent Developments Are Shaping the Gossamer Bio Investment Story - Yahoo Finance
Gossamer Bio, Inc.'s (NASDAQ:GOSS) 28% Share Price Surge Not Quite Adding Up - simplywall.st
Gossamer Bio to Participate in Upcoming December 2025 Investor Conferences - BioSpace
Gossamer Bio to Participate in Upcoming Investor Conferences - Enidnews.com
Gossamer Bio, Inc. (NASDAQ:GOSS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Analysts Offer Predictions for Gossamer Bio FY2025 Earnings - MarketBeat
GOSS News Today | Why did Gossamer Bio stock go down today? - MarketBeat
How Gossamer Bio Inc. (4GB) stock reacts to fiscal policiesWeekly Trend Summary & Consistent Growth Equity Picks - newser.com
How Gossamer Bio Inc. (4GB) stock moves in volatile trading sessionsMarket Risk Analysis & Stock Portfolio Risk Management - newser.com
What downside risks could hit Gossamer Bio Inc. (4GB) stock2025 Winners & Losers & Detailed Earnings Play Strategies - newser.com
Volume spikes in Gossamer Bio Inc. stock – what they meanPortfolio Risk Summary & Accurate Trade Setup Notifications - newser.com
Strategies to average down on Gossamer Bio Inc.2025 Trading Recap & Long Hold Capital Preservation Tips - newser.com
Will Gossamer Bio Inc. stock benefit from sector rotationJuly 2025 Short Interest & Low Risk High Reward Ideas - newser.com
Why Gossamer Bio Inc. (4GB) stock could outperform next yearMarket Sentiment Report & Entry Point Confirmation Alerts - newser.com
Is now a turning point for Gossamer Bio Inc.July 2025 Market Mood & Real-Time Stock Movement Alerts - newser.com
Is Gossamer Bio Inc. stock near bottom after declineJuly 2025 Pullbacks & Safe Entry Point Identification - newser.com
Ranking Gossamer Bio Inc. among high performing stocks via toolsQuarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
Why retail investors favor Gossamer Bio Inc. stockTreasury Yields & Advanced Swing Trade Entry Alerts - newser.com
Why Gossamer Bio Inc. stock remains undervalued2025 Risk Factors & Reliable Momentum Entry Alerts - newser.com
What valuation multiples suggest for Gossamer Bio Inc. stockBuy Signal & Community Verified Watchlist Alerts - newser.com
Gossamer Bio Inc (GOSS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):